Congress creates health panel—but stacks it with industry insiders
H.R. 751 — HEALTH Panel Act · Filed by Buddy Carter (R-GA) · 1 cosponsor · Introduced Jan 28, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill creates a 15-member Panel of Health Advisors within the Congressional Budget Office to provide expert recommendations on health care cost estimates, policy analysis, and economic modeling. The panel will meet annually, issue public reports, and advise Congress on how health legislation may affect budgets and outcomes—bringing in expertise from economists, doctors, actuaries, and health industry professionals to improve the accuracy of congressional health care cost projections.
Why we flagged it
The bill's core function is establishing a permanent advisory body within the CBO to improve health policy analysis and cost estimation. It is procedural and institutional, not substantive legislation that directly regulates health care or spending.
What the text implies
- Panel membership includes representatives from health care investment and pharmaceutical sectors, creating potential for industry influence over CBO health cost estimates—the very figures Congress relies on to evaluate health legislation.
- The bill requires the CBO Director to 'consider recommendations' from Budget Committee chairs when selecting the chair and vice chair, but final selection remains with the Director, creating ambiguity about political vs. merit-based appointment.
The full analysis lists 4 implications of this text.
Who stands to gain
health insurance companies; pharmaceutical manufacturers; hospital systems and health care facility operators